Inovio Pharmaceuticals Inc. (NASDAQ: INO)
$10.83
-0.3000 ( -2.70% ) 97.0K
Inovio Pharmaceuticals Inc is a United States-based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Market Data
Open
$10.83
Previous close
$11.13
Volume
97.0K
Market cap
$280.61M
Day range
$10.71 - $11.32
52 week range
$3.89 - $14.75
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 13 | Oct 10, 2023 |
| 10-q | Quarterly Reports | 76 | Aug 09, 2023 |
| 8-k | 8K-related | 13 | Aug 09, 2023 |
| 8-k | 8K-related | 12 | Aug 01, 2023 |